| [1] |
ZHAO M, ZHUO C, LI Q, et al. Cytomegalovirus (CMV) infection in HIV/AIDS patients and diagnostic values of CMV-DNA detection across different sample types[J].Ann Palliat Med,2020,9(5):2710-2715. |
| [2] |
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J].中国艾滋病性病,2021,27(11):1182-1201. |
|
Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome (2021 edition)[J].Chin J AIDS STD,2021,27(11):1182-1201. |
| [3] |
张莉. 艾滋病合并巨细胞病毒感染特点及危险因素的研究[J].国际检验医学杂志,2018,39(3):293-295,299. |
|
ZHANG L. Characteristics of AIDS complicating cytomegalovirus infection and the risk factors[J].Int J Lab Med,2018,39(3):293-295,299. |
| [4] |
SPIES R, JOUBERT P, CHETTY D, et al. Multisystem cytomegalovirus end-organ disease in a patient with advanced HIV[J].S Afr J Infect Dis,2022,37(1):468. doi:10.4102/sajid.v37i1.468pmid:36483572 |
| [5] |
SUN L, CHEN J M, YANG K, et al. Cytomegalovirus cell tropism and clinicopathological characteristics in gastrointestinal tract of patients with HIV/AIDS[J].Diagn Pathol,2022,17(1):9. doi:10.1186/s13000-022-01193-9pmid:35027044 |
| [6] |
FANG M, LIN X, WANG C, et al. High cytomegalovirus viral load is associated with 182-day all-cause mortality in hospitalized people with human immunodeficiency virus[J].Clin Infect Dis,2023,76(7):1266-1275. |
| [7] |
李明远, 徐志凯.医学微生物学[M]. 第3版. 北京: 人民卫生出版社, 2016:383-397. |
|
LI M Y, XU Z K.Medical microbiology[M]. 3rd ed. Beijing: People's Medical Publishing House,2016:383-397. |
| [8] |
姜支农, 石雪迎, 周炜洵, 等. 活检标本炎症性肠病规范化病理诊断建议[J].中华病理学杂志,2019,48(2):81-86. |
|
JIANG Z N, SHI X Y, ZHOU W X, et al. Proposal of standardized pathological diagnosis for inflammatory bowel disease through biopsies[J].Chin J Pathol,2019,48(2):81-86. |
| [9] |
GRABAR S, LE MOING V, GOUJARD C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy[J].Ann Intern Med,2000,133(6):401-410. doi:10.7326/0003-4819-133-6-200009190-00007pmid:10975957 |
| [10] |
AFFANDI J S, MONTGOMERY J, BRUNT S J, et al. The immunological footprint of CMV in HIV-1 patients stable on long-term ART[J].Immun Ageing,2015,12:14. |
| [11] |
韦林华, 张彤, 吴锋耀, 等. HAART时代HIV/AIDS住院病人机会性感染疾病谱分析[J].中国艾滋病性病,2018,24(5):454-457. |
|
WEI L H, ZHANG T, WU F Y, et al. Analysis of the opportunistic infections′spectrum in hospitalized patients with HIV/AIDS in the era of HAART[J].Chin J AIDS STD,2018,24(5):454-457. |
| [12] |
陈永宏. HAART治疗对AIDS机会性感染的影响研究[J].河北医药,2016,38(2):218-220. |
|
CHEN Y H. Effect of HAART treatment on AIDS opportunistic infection[J].Hebei Med J,2016,38(2):218-220. |